HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$7.55
Day range
$7.60 - $8.20
Year range
$6.11 - $18.94
Market cap
742.96M USD
Avg Volume
78.52K
P/E ratio
191.21
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 26.77M | 6.13% |
Operating expense | 23.45M | 10.64% |
Net income | 442.00K | -87.47% |
Net profit margin | 1.65 | -88.21% |
Earnings per share | — | — |
EBITDA | 2.81M | -19.40% |
Effective tax rate | 29.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.36M | 116.59% |
Total assets | 152.65M | 26.23% |
Total liabilities | 23.20M | -15.88% |
Total equity | 129.44M | — |
Shares outstanding | 90.83M | — |
Price to book | 7.48 | — |
Return on assets | 3.84% | — |
Return on capital | 4.59% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 442.00K | -87.47% |
Cash from operations | 2.09M | 138.01% |
Cash from investing | -3.04M | 63.23% |
Cash from financing | 22.35M | 14,227.56% |
Net change in cash | 21.45M | 256.68% |
Free cash flow | 2.37M | 135.48% |
About
Founded
1997
Headquarters
Website
Employees
579
